Summit Therapeutics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | -66.3% | -66.3% | -51.4% |
| FY2021 | -106.4% | -106.4% | -78.2% |
| FY2022 | -62.2% | -62.2% | -11.9% |
| FY2023 | -791.5% | -791.5% | -303.0% |
| FY2024 | -56.9% | -56.9% | -50.8% |
| FY2025 | -163.9% | -163.9% | -143.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | -66.3% | -66.3% | -51.4% |
| FY2021 | -106.4% | -106.4% | -78.2% |
| FY2022 | -62.2% | -62.2% | -11.9% |
| FY2023 | -791.5% | -791.5% | -303.0% |
| FY2024 | -56.9% | -56.9% | -50.8% |
| FY2025 | -163.9% | -163.9% | -143.7% |